1Seherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to Clq, produced exclusively in adipocytes [ J ]. J Biol Chem, 1995,270(45) : 26 746.
2Arita Y, Kihara S, Ouchi N,Takahashi M, Maeda K, miyagawa J, et al. Paradoxical decrease of and adipose-specific protein, adiponectin, in obesity[ J]. Biochem Biophys Res Commu, 1999,257(1) : 79.
3Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests and evolutionary link to tumor necrosis factor[ J]. Curt bIOL, 1998,8:335.
4Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J]. Nature,2004,423:762.
5Chinetti G, Zawadski C, Fruchart JC, et al. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptor PPP ARalpha, PPAR gamma, and LXR[ J]. Biochem Biophys Res Commu,2004,314:151.
6Hug C,Wand J, Ahmad NS, et al. Tcadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponeetin[J]. Proc Natl Acad SCI usa,2004,10:10308.
7Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin [ J ]. Dibetes, 2003,52( 2 ) : 268.
8Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J]. Nat Med,2001,7(8) :941.
9Pellme F, Smith U, Funahashi T, et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients[J]. Diabetes,2003,52(5) : 1182.
10Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk fartor for the progression to type 2 diabetes in the Japanese population[J]. Diabetes Care,2003,26(7):2015.
2Bajaj M,Suraamornkul S,Piper P,et al.Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.J Clin Endocrinol Metab,2004,89:200 ～ 206.
3Berg A H,Combs T P,Du X,et al.The adipocyte secreted protein Aerp30 enhances hepatic insulin action.Nat Med,2001,7:947～953.
4Beylot M,Pinteur C,Peroni O.Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats.Metabolism,2006,55:396 ～401.
5Bugianesi E,Pagotto U,Manini R,et al.Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content,not to liver disease severity.J Clin Endocrinol Metab,2005,90:3498～3504.
6Civitarese A E,Ukropcova B,Carling S,et al.Role of adiponectin in human skeletal muscle bioenergetics.Cell Metab,2000,4:75～87.
7Hotta K,Funahashi T,Bodkin N L,et al.Circulating concentrations of the adipocyte protein adiponecrin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.Diabetes,2001,50:1126 ～ 1133.
8Hu E,Liang P,Spiegelman B M.AdipoQ is a novel adipose-specific gene dysregulated in obesity.J Biol Chem,1996,271:10697～ 10703.
9Kadowaki T,Yamauchi T,Kubota N,et al.Adiponectin and adiponectin receptors in insulin resistance,diabetes,and the metabolic syndrome.J Clin Invest,2006,116:1784 ～ 1792.
10Kato H,Kashiwagi H,Shiraga M,et al.Adiponectin acts as an endogenous antithrombotic factor.Arterioscler Thromb Vasc Biol,2006,26:224～230.
